Pregnancy in Inflammatory Arthritis: What Your Patients Need to Know
Megan Clowse, MD, MPH, discusses 2 studies that examine reproductive health concerns in women with inflammatory rheumatic diseases.
ACR 2017
Inhibition of the Wnt Pathway: Potential Benefits for Osteoarthritis
Allan Gibofsky, MD, discusses inhibition of the Wnt pathway and its potential benefits for the treatment of osteoarthritis.
Reduced Fracture Risk With Abaloparatide, Alendronate in Postmenopausal Women
This suggests to us that, as is the standard now, when we use an anabolic agent, we can add in an antiresorptive such as alendronate, and see continued sustained reduction in fracture risk.
The Future of Precision Medical Care for Rheumatic Disease
Virginia Pascual, MD, discusses precision medicine for rheumatic diseases.
Treatment Options to Explore When Serum Uric Acid Targets Are Not Attained
Machelle Manuel, PhD, discusses further gout treatment options to consider when target serum urate levels are not attained.
Assessment of Life Expectancy in Scleroderma-Associated Pulmonary Arterial Hypertension
Patients with scleroderma-associated isolated pulmonary arterial hypertension (SSc-PAH) have a slightly higher mortality risk than patients SSc-PAH with concomitant interstitial lung disease.
Pulmonary Arterial Hypertension in Systemic Sclerosis: Swift Diagnosis and Effective Treatment
Rheumatology specialists should be aware of the clinical features of SSc-PAH, as well as the tools available to facilitate a prompt, accurate diagnosis.
Association Between SLE Disease Activity and Omega Fatty Acids, Vitamin D
Low vitamin D is linked with later total organ and renal damage in patients with SLE.
Medications Linked With Increased Osteoporotic Fracture Risk in Rheumatoid Arthritis
Opioids and SSRIs are linked to an increased risk of osteoporotic fractures in RA patients.
Rituximab Effectively Treats Relapsing ANCA-Associated Vasculitis
Results from the largest prospective study of rituximab use in patients with relapsing ANCA-associated vasculitis show that 91.2% of participants achieved remission.
Next post in ACR 2017 Coverage
